Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
459
1.830
 Why?
Endometrial Neoplasms
5
2015
144
0.840
 Why?
Gynecology
5
2020
52
0.800
 Why?
Genital Neoplasms, Female
2
2020
48
0.750
 Why?
Gene Expression Regulation, Neoplastic
10
2019
858
0.730
 Why?
Cystadenocarcinoma, Serous
4
2021
73
0.700
 Why?
Infection Control
1
2020
46
0.660
 Why?
Ethics, Medical
1
2020
43
0.650
 Why?
Communication
1
2020
257
0.580
 Why?
Conflict of Interest
3
2016
26
0.580
 Why?
Uterus
1
2018
88
0.570
 Why?
Medical Oncology
3
2020
104
0.560
 Why?
Robotics
2
2014
43
0.550
 Why?
Pneumonia, Viral
1
2020
177
0.540
 Why?
Peptides
3
2015
229
0.530
 Why?
Coronavirus Infections
1
2020
188
0.530
 Why?
Receptors, Estrogen
5
2017
132
0.530
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.500
 Why?
Fallopian Tube Neoplasms
2
2013
15
0.500
 Why?
Antineoplastic Agents, Hormonal
1
2015
53
0.480
 Why?
Pandemics
1
2020
585
0.480
 Why?
Glycoproteins
1
2015
123
0.480
 Why?
Gynecologic Surgical Procedures
2
2014
28
0.470
 Why?
Neoplastic Stem Cells
1
2015
93
0.470
 Why?
Antigens, CD
1
2015
219
0.450
 Why?
Adenocarcinoma
2
2015
405
0.450
 Why?
Salpingectomy
1
2013
6
0.410
 Why?
Female
34
2023
28105
0.410
 Why?
Pelvic Neoplasms
1
2013
13
0.410
 Why?
General Surgery
1
2014
106
0.410
 Why?
Peritoneal Neoplasms
2
2011
65
0.400
 Why?
MicroRNAs
4
2021
387
0.400
 Why?
Estrogens
2
2012
223
0.400
 Why?
Clinical Trials as Topic
2
2007
468
0.380
 Why?
Medicare Part B
1
2011
5
0.370
 Why?
Professional Corporations
1
2011
1
0.370
 Why?
Marketing of Health Services
1
2011
7
0.370
 Why?
Reimbursement Mechanisms
1
2011
24
0.370
 Why?
Physicians
2
2016
240
0.370
 Why?
Social Responsibility
1
2011
25
0.360
 Why?
Receptors, Progesterone
4
2015
66
0.360
 Why?
Cell Line, Tumor
11
2016
1436
0.360
 Why?
Trust
1
2011
63
0.350
 Why?
Carcinoma, Large Cell
1
2010
17
0.350
 Why?
Humans
42
2023
52336
0.350
 Why?
Carcinoma, Neuroendocrine
1
2010
25
0.350
 Why?
Health Care Reform
1
2010
22
0.340
 Why?
Interprofessional Relations
1
2011
91
0.340
 Why?
Physician-Patient Relations
1
2011
144
0.330
 Why?
Breast Neoplasms
4
2012
1206
0.320
 Why?
Uterine Neoplasms
2
2019
60
0.290
 Why?
Transplantation, Heterologous
2
2012
79
0.290
 Why?
Uterine Cervical Neoplasms
1
2010
299
0.280
 Why?
Physician's Role
2
2011
50
0.270
 Why?
MAP Kinase Kinase 4
1
2007
30
0.270
 Why?
Apoptosis
5
2016
1127
0.270
 Why?
Genes, Tumor Suppressor
1
2007
74
0.260
 Why?
Advance Directives
1
2007
29
0.260
 Why?
Patient Dropouts
1
2007
51
0.260
 Why?
Gene Expression Regulation, Enzymologic
1
2007
181
0.240
 Why?
Claudin-4
2
2016
7
0.240
 Why?
Receptors, Transforming Growth Factor beta
1
2005
29
0.240
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1031
0.230
 Why?
Ovary
1
2004
107
0.220
 Why?
Hysterectomy
2
2014
90
0.220
 Why?
Epithelial Cells
1
2004
215
0.200
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
583
0.200
 Why?
Aged
11
2021
10109
0.200
 Why?
Neoplasm Staging
4
2021
770
0.190
 Why?
Middle Aged
12
2021
13014
0.190
 Why?
Gene Expression Profiling
3
2019
1110
0.180
 Why?
Cisplatin
2
2015
285
0.180
 Why?
Immunohistochemistry
6
2017
985
0.170
 Why?
Cell Movement
3
2016
277
0.170
 Why?
Resource Allocation
1
2020
14
0.170
 Why?
Standard of Care
1
2020
17
0.170
 Why?
Disclosure
2
2016
41
0.170
 Why?
Loss of Heterozygosity
2
2013
78
0.170
 Why?
Lymphatic Metastasis
2
2010
212
0.160
 Why?
Leiomyosarcoma
1
2019
21
0.160
 Why?
Leiomyoma
1
2019
23
0.160
 Why?
Early Detection of Cancer
1
2021
183
0.160
 Why?
Neoplasm Invasiveness
3
2015
278
0.160
 Why?
Xenograft Model Antitumor Assays
4
2012
222
0.150
 Why?
Informed Consent
3
2004
96
0.150
 Why?
RNA-Binding Proteins
2
2019
134
0.150
 Why?
Death
1
2018
23
0.150
 Why?
Critical Care
1
2020
216
0.150
 Why?
Living Donors
1
2018
27
0.150
 Why?
Neoplasms, Glandular and Epithelial
2
2015
41
0.150
 Why?
Palliative Care
1
2020
214
0.140
 Why?
Carcinosarcoma
1
2017
18
0.140
 Why?
Microfilament Proteins
1
2017
43
0.140
 Why?
Sequence Analysis, RNA
1
2017
99
0.130
 Why?
Mice, Nude
3
2012
236
0.130
 Why?
United States
4
2016
5182
0.130
 Why?
Adult
7
2021
14139
0.130
 Why?
Industry
1
2016
16
0.130
 Why?
Keratin-5
1
2015
2
0.120
 Why?
Cell Count
1
2015
144
0.120
 Why?
Receptors, Androgen
1
2015
47
0.120
 Why?
Carrier Proteins
1
2017
326
0.120
 Why?
Cell Proliferation
4
2015
1029
0.120
 Why?
Prognosis
4
2017
2094
0.120
 Why?
Neoplasm Seeding
1
2014
4
0.120
 Why?
Genetic Privacy
2
2004
3
0.110
 Why?
Alanine
1
2014
44
0.110
 Why?
Triazines
1
2014
26
0.110
 Why?
Endometrium
1
2014
43
0.110
 Why?
Genes, BRCA2
1
2013
13
0.100
 Why?
Genes, BRCA1
1
2013
19
0.100
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.100
 Why?
Mice
6
2016
5965
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
7
0.100
 Why?
Health Care Costs
2
2013
175
0.100
 Why?
DNA Methylation
3
2023
592
0.100
 Why?
Risk Reduction Behavior
1
2013
58
0.100
 Why?
Carcinoma, Lobular
1
2012
32
0.100
 Why?
DNA-Binding Proteins
2
2013
429
0.100
 Why?
Lymph Nodes
1
2014
252
0.100
 Why?
Paclitaxel
1
2012
90
0.100
 Why?
Antibodies, Neoplasm
1
2012
27
0.100
 Why?
Judicial Role
1
2011
6
0.090
 Why?
Coercion
1
2011
9
0.090
 Why?
Medicare Payment Advisory Commission
1
2011
2
0.090
 Why?
Personal Autonomy
1
2011
16
0.090
 Why?
Women
1
2011
30
0.090
 Why?
Prejudice
1
2011
37
0.090
 Why?
Homeodomain Proteins
1
2012
81
0.090
 Why?
Quality of Health Care
1
2013
187
0.090
 Why?
Politics
1
2011
28
0.090
 Why?
Violence
1
2011
62
0.090
 Why?
M Phase Cell Cycle Checkpoints
1
2011
5
0.090
 Why?
Taxoids
1
2011
37
0.090
 Why?
Selective Estrogen Receptor Modulators
1
2010
23
0.090
 Why?
Immunoenzyme Techniques
1
2010
137
0.090
 Why?
Organ Specificity
1
2010
117
0.090
 Why?
RNA, Messenger
2
2012
1142
0.090
 Why?
Obstetrics
1
2011
89
0.090
 Why?
Models, Statistical
1
2011
230
0.080
 Why?
Cesarean Section
1
2011
184
0.080
 Why?
Neoplasm Recurrence, Local
1
2014
643
0.080
 Why?
Alcohol Drinking
1
2011
236
0.080
 Why?
Blotting, Western
1
2010
596
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
412
0.080
 Why?
Societies, Medical
1
2010
200
0.080
 Why?
Transfection
2
2012
372
0.080
 Why?
Phosphorylation
2
2008
531
0.080
 Why?
Animals
6
2016
13523
0.070
 Why?
Aging
1
2013
708
0.070
 Why?
Aged, 80 and over
4
2021
3391
0.070
 Why?
Alleles
2
2006
277
0.070
 Why?
Case-Control Studies
2
2014
1201
0.070
 Why?
Chimera
1
2007
10
0.070
 Why?
Antineoplastic Agents
1
2015
1222
0.070
 Why?
CpG Islands
1
2007
121
0.060
 Why?
Genomic Imprinting
1
2006
12
0.060
 Why?
MAP Kinase Signaling System
1
2007
127
0.060
 Why?
Insulin-Like Growth Factor II
1
2006
18
0.060
 Why?
RNA, Untranslated
1
2006
15
0.060
 Why?
Health Services Accessibility
1
2010
437
0.060
 Why?
Base Sequence
1
2007
648
0.060
 Why?
Repetitive Sequences, Amino Acid
1
2005
1
0.060
 Why?
Molecular Sequence Data
1
2007
792
0.060
 Why?
Models, Biological
2
2008
743
0.060
 Why?
North Carolina
1
2005
56
0.060
 Why?
Databases, Nucleic Acid
1
2004
10
0.060
 Why?
Carcinoma
1
2006
137
0.060
 Why?
Telomerase
1
2004
26
0.060
 Why?
Promoter Regions, Genetic
1
2007
474
0.060
 Why?
Polymorphism, Genetic
1
2005
185
0.060
 Why?
RNA Interference
2
2016
186
0.060
 Why?
RNA, Small Interfering
2
2016
218
0.060
 Why?
Tumor Burden
2
2016
136
0.060
 Why?
Cell Survival
2
2016
602
0.060
 Why?
Family Health
1
2004
79
0.050
 Why?
Genetic Counseling
1
2004
44
0.050
 Why?
Genomics
1
2004
270
0.050
 Why?
Epigenesis, Genetic
1
2006
407
0.050
 Why?
Researcher-Subject Relations
1
2002
1
0.050
 Why?
Ethical Review
1
2002
2
0.050
 Why?
Contract Services
1
2002
13
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Health Care Sector
1
2002
15
0.050
 Why?
Genetic Predisposition to Disease
1
2005
528
0.050
 Why?
Mice, SCID
2
2012
182
0.050
 Why?
Biotechnology
1
2002
15
0.050
 Why?
Cell Line
1
2004
1045
0.050
 Why?
Drug Industry
1
2002
40
0.050
 Why?
Research Support as Topic
1
2002
44
0.050
 Why?
Research Subjects
1
2002
52
0.050
 Why?
Neoplasm Grading
1
2021
126
0.040
 Why?
Patient Selection
1
2002
259
0.040
 Why?
Cooperative Behavior
1
2002
228
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
11
0.040
 Why?
Cytoskeletal Proteins
1
2019
48
0.040
 Why?
Microtubule-Associated Proteins
1
2019
65
0.040
 Why?
Risk Assessment
1
2023
1323
0.040
 Why?
Biomedical Research
1
2002
256
0.040
 Why?
Cell Cycle Proteins
1
2019
173
0.040
 Why?
Sensitivity and Specificity
1
2019
879
0.030
 Why?
Cohort Studies
1
2021
1532
0.030
 Why?
Caspase 3
1
2016
94
0.030
 Why?
Retrospective Studies
2
2021
6578
0.030
 Why?
Tissue Array Analysis
1
2015
46
0.030
 Why?
Diagnosis, Differential
1
2019
1044
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
58
0.030
 Why?
Prospective Studies
1
2021
2428
0.030
 Why?
HEK293 Cells
1
2015
232
0.030
 Why?
Exosomes
1
2015
56
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
10
0.030
 Why?
Peritoneal Cavity
1
2014
8
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
184
0.030
 Why?
Risk Factors
2
2014
3872
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
186
0.030
 Why?
Disease-Free Survival
1
2014
460
0.030
 Why?
Drug Resistance, Neoplasm
1
2015
327
0.030
 Why?
MCF-7 Cells
1
2013
62
0.030
 Why?
Germ-Line Mutation
1
2013
66
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Amino Acid Substitution
1
2013
82
0.030
 Why?
Karyotyping
1
2012
78
0.030
 Why?
Extracellular Matrix Proteins
1
2013
69
0.030
 Why?
Anoikis
1
2012
8
0.030
 Why?
Transduction, Genetic
1
2012
44
0.020
 Why?
Tubulin
1
2012
22
0.020
 Why?
Databases, Factual
1
2016
706
0.020
 Why?
Mice, Inbred NOD
1
2012
92
0.020
 Why?
Tamoxifen
1
2012
60
0.020
 Why?
DNA Fingerprinting
1
2012
61
0.020
 Why?
Signal Transduction
2
2011
1716
0.020
 Why?
Cell Adhesion
1
2012
164
0.020
 Why?
Antibody Specificity
1
2012
36
0.020
 Why?
Amino Acid Sequence
1
2013
591
0.020
 Why?
Perioperative Period
1
2011
22
0.020
 Why?
Tumor Suppressor Protein p53
1
2013
224
0.020
 Why?
Estradiol
1
2012
215
0.020
 Why?
Disease Models, Animal
1
2016
1484
0.020
 Why?
Microtubules
1
2011
39
0.020
 Why?
Cell Cycle Checkpoints
1
2011
32
0.020
 Why?
Gene Expression
1
2013
623
0.020
 Why?
Mitosis
1
2011
89
0.020
 Why?
Regression Analysis
1
2011
401
0.020
 Why?
HeLa Cells
1
2011
263
0.020
 Why?
Disease Progression
1
2012
870
0.020
 Why?
Cells, Cultured
1
2013
1589
0.020
 Why?
Severity of Illness Index
1
2011
1021
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Progesterone
1
2008
58
0.020
 Why?
Mutation
1
2013
1351
0.020
 Why?
Protein Kinases
1
2008
74
0.020
 Why?
Tumor Cells, Cultured
1
2008
456
0.020
 Why?
Cell Nucleus
1
2008
191
0.020
 Why?
Transcriptional Activation
1
2006
128
0.020
 Why?
DNA, Neoplasm
1
2006
146
0.020
 Why?
Protein Structure, Tertiary
1
2006
252
0.020
 Why?
Binding Sites
1
2006
379
0.010
 Why?
Repressor Proteins
1
2006
156
0.010
 Why?
Pregnancy
1
2011
2675
0.010
 Why?
Truth Disclosure
1
2004
16
0.010
 Why?
Genetic Diseases, Inborn
1
2004
24
0.010
 Why?
Male
1
2011
26696
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (37) people
_